ACC 2009 schedule

Jump to navigation Jump to search

Here is the page we will use to coordinate interviews at ACC 2009

Filming location: Rosen Plaza Hotel 9700 International Drive Phone: 407-996-9700

Filming will occur from Saturday to Tuesday (March 28 - March 31). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. As a presenter, you should go ahead and speak about your topic/present your slides.



Click on Date for Detailed Schedule

Saturday March 28, 2009

Sunday March 29, 2009

Monday March 30, 2009

Tuesday March 31, 2009


Saturday, March 28, 2009

Presentations will occur throughout the day on Saturday. Dr. Gibson will not be available to interview between 2:00 and 5:00 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

2:00 PM

  • Interviewee: Gilles Montalescot (Slide presentation)
  • Confirmed (Y/N): Y
  • Trial: Immediate Versus Next Day Catheterization in Non-ST Elevation Acute Coronary Syndrome: Results of the Multicenter Randomized ABOARD Study
  • Phone number: +33 6 12592326

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

Return to top

Sunday March 29, 2009

Presentations will occur throughout the day on Sunday. Dr. Gibson will not be available to interview between 7:00 AM and 8:30 AM, 2:00 to 3:30 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

  • Interviewee: Ted Feldman, MD, FSCAI,
  • Confirmed: Y
  • Topic: Evalve, SYNTAX, and PFO for stroke + migraine
  • On-site phone:

4:30 PM

  • Interviewee: Davy Cheng
  • Confirmed (Y/N): Y
  • Trial: Endovascular Versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
  • Phone number: 519-859-0219

5:00 PM

  • Interviewee: Christian Hamm
  • Confirmed (Y/N): Y
  • Trial: Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One-Year Outcome of ON-TIME-2
  • Phone number: + 49 172 69 36 243

Return to top

Monday March 30, 2009

Presentations will occur throughout the day on Monday. Dr. Gibson will not be available to interview between 12:00 and 2:00 PM, 4:30 to 5:30 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

8:30 AM

  • Interviewee: David Cohen
  • Confirmed: Y
  • Trial: Health Related Quality of Life and U.S. Based Economic Outcomes of PCI With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results From the SYNTAX Trial
  • On-site phone: 617-519-0310

9:00 AM

  • Interviewee: Mark Creager
  • Confirmed: Y
  • Trial: Treatment of Intermittent Claudication With Hypoxia-Inducible Factor-1α
  • On-site phone:

9:30 AM

10:00 AM

  • Interviewee: Robert Hendel
  • Confirmed: Y
  • Trial: Multicenter Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria: The ACCF and United HealthCare SPECT Pilot Study
  • On-site phone: 630-310-2162

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

  • Interviewee: Mark Turco, MD, FSCAI (Slide presentation)
  • Confirmed: Y
  • Topic: Comparative Effectiveness Research
  • On-site phone: 301-938-3485

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

5:30 PM

Return to top

Tuesday March 31, 2009

Presentations will occur throughout the day on Tuesday. Dr. Gibson will not be available to interview between 1:30 and 3:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

8:30 AM

9:00 AM

  • Interviewee: L. Kristin Newby and Robert Giugliano
  • Confirmed (Y/N): Y
  • Trial: Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS)
  • Phone number: 617-842-8320 (Dr. Giugliano), 919-612-3305 (Dr. Newby)

9:30 AM

10:00 AM

10:30 AM

11:00 AM

  • Interviewee: George Dangas, MD, PhD, FSCAI
  • Confirmed: Y
  • Topic: TBD
  • On-site phone: 917-432-4286

11:30 AM

12:00 PM

  • Interviewee: George Dangas
  • Confirmed (Y/N): Y
  • Trial: Predictors of Stent Thrombosis After Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial
  • Phone number: 917-432-4286

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

  • Interviewee: Raimund Erbel
  • Confirmed: Y
  • Topic: Signs of Subclinical Coronary Atherosclerosis Measured as Coronary Artery Calcification Improve Risk Prediction of Hard Events Beyond Traditional Risk Factors in an Unselected General Population: The Heinz Nixdorf Recall Study Five-Year Outcome Data
  • On-site phone: 49 173 283 7339

5:00 PM

5:30 PM

Return to top